CGRP antagonists 5 years in - what have we learned?
MIG-ES-NP-00119 (Marzo 2024)
Dra. Carmen González Oria
Hospital Universitario Virgen del Rocío, Sevilla
“CGRP antagonists 5 years in - what have we learned?”: Resumen de la sesión científica del IHC moderada por Rami Burstein donde se abordan en detalle las tres siguientes temáticas:
- Brain functions altered by peripherally acting CGRP inhibitors: lessons learned from prodromes and triggers. Rami Burstein
- Emerging information on similarities and differences between CGRP antibody and small molecule treatments. Antoinette Maassen van den Brink
- Clinical management and side effect profiles of different CGRP antagonists. Hans Christoph Diener